Sinovac Biotech Ltd (NASDAQ:SVA)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2019
AssetsCash50.8M54.6M65.4M149.0M
 
 
 
 
 
Short Term Investment Cash-13.3M5.2M9.5M-9.1M
 
 
 
 
 
Cash & Short Term Investments50.8M54.6M65.4M168.4M
 
 
 
 
 
 
ReceivablesReceivables29.6M47.5M49.8M82.0M
 
 
 
 
 
 
InventoriesInventories21.5M19.6M14.1M29.8M
 
 
 
 
 
 
Current AssetsOther Current Assets4.8M4.2M4.9M3.1M
 
 
 
 
 
Current Assets106.8M125.9M134.2M283.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----106.2M--
 
 
Depreciation-----38.4M--
 
 
Other Assets9.3M9.2M8.8M8.6M
 
 
 
 
 
Total Assets181.4M203.7M211.4M381.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable22.1M26.0M1.8M46.6M
 
 
 
 
 
Short Term Debt26.2M31.8M33.6M5.3M
 
 
 
 
 
Accrued Expenses----8.6M--
 
 
Other Current Liabilities2.0M7.3M22.3M4.0M
 
 
 
 
 
Other Liabilities50.6M66.0M66.3M56.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.0M6.0M9.4M15.7M
 
 
 
 
 
Deferred Taxes-539.0K-428.0K-452.0K-6.6M
 
 
 
 
 
Other Liabilities737.0K734.0K2.9M3.1M
 
 
 
 
 
Total Liabilities54.4M72.8M78.7M75.4M
 
 
 
 
 
 
EquityMinority Interest-3.0M-1.1M-2.4M-1.8M
 
 
 
 
 
Preferred Stock0.000.000.0015.0K
 
 
Common Equity111.8M115.0M115.8M259.1M
 
 
 
 
 
Total Shareholder Equity111.8M115.0M115.8M259.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding56.9M56.9M57.0M99.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.